article

Cell line development – global market drivers, trends and its impact on improving biologics development from early phase to IND during the drug discovery process

Cell line development is a major step for examining the efficiency of drug discovery, toxicity and in-vitro testing. It reduces time, effort and cost, which minimises the chance of research drugs failing at the clinical trial stage. This stage involves the production of recombinant proteins such as monoclonal antibodies, bi-specific monoclonal antibodies, growth factors, enzymes and the latest novel approach of developing immunotherapy for the treatment of cancer using a wide variety of expression systems.











To read this article in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: FortéBio

Send this to a friend